Lonza has announced the launch of its AI-enabled Route Scouting Service, a new offering designed to streamline synthetic route identification for novel Active Pharmaceutical Ingredients (APIs). This innovative service combines Lonza’s extensive process R&D expertise and supply chain databases with AI
Lonza has expanded its service offering for spray-drying of proteins for pulmonary delivery. The new offering reportedly provides clinical and commercial manufacturing services at a kilogram scale from Lonza’s Bend-OR site, home to Lonza’s Center of Excellence for respiratory delivery.
Lonza, one of the world’s largest healthcare manufacturing organisations, has announced its acquisition of Genentech’s biologics manufacturing facility in Vacaville, California. The deal, worth $1.2 billion, is set to bolster Lonza’s large-scale biologics manufacturing capacity for both commercial-scale mammalian contract
Interview with Julien Lamps, Associate Director of Global Product Management at Lonza Capsules and Health Ingredients
Vertex Pharmaceuticals and Lonza have recently announced a strategic collaboration aimed at supporting the manufacturing of Vertex’s portfolio of investigational stem cell-derived, fully differentiated insulin-producing islet cell therapies for people with Type 1 Diabetes. The 130,000ft² site will be run
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
